PATH three-lens brief
Evidence-based stock research on PATH. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved +2.77% yesterday. · Trading at 10% of its 52-week range — deep in the lower band.
- Moved +2.77% yesterday.
- Trading at 10% of its 52-week range — deep in the lower band.
- Underperforming SPY by 16.0pp over 30 days.
- Analyst mean target $13.80 — 33% above current (16 analysts).
- Debt-to-equity of 3.9 — balance-sheet-heavy.
PATH closed at $10.37 (+2.77%) as of 2026-04-25. Market cap: $5.43B. P/E (trailing) 19.9. Positives: moved +2.77% yesterday.; analyst mean target $13.80 — 33% above current (16 analysts).. Concerns: trading at 10% of its 52-week range — deep in the lower band.; underperforming SPY by 16.0pp over 30 days.. Last quarter: Revenue $481.11M, net income $104.46M, free cash flow $473.55M.
Why three lenses on PATH, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PATHacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PATH" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PATH brief"></iframe>